NanoViricides
NNVC
#10134
Rank
HK$0.26 B
Marketcap
HK$11.83
Share price
2.03%
Change (1 day)
3.57%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: HK$0.26 Billion

As of May 2026 NanoViricides has a market cap of HK$0.26 Billion. This makes NanoViricides the world's 10134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.26 B34.91%
2025HK$0.19 B19.53%
2024HK$0.16 B78.55%
2023HK$93.57 M-7.07%
2022HK$0.10 B-69.88%
2021HK$0.33 B40.89%
2020HK$0.23 B213.61%
2019HK$75.66 M-30.49%
2018HK$0.10 B-75.01%
2017HK$0.43 B-9.82%
2016HK$0.48 B-8.68%
2015HK$0.52 B-55.69%
2014HK$1.19 B-35.93%
2013HK$1.86 B221.15%
2012HK$0.57 B-18.03%
2011HK$0.70 B-55.44%
2010HK$1.58 B82.63%
2009HK$0.86 B13.19%
2008HK$0.76 B111.98%
2007HK$0.36 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of NanoViricides was reported to be:

HK$0.25 Billion
by Nasdaq info icon info icon
HK$0.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
HK$1.260 T 467,929.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.177 T 808,089.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$916.65 B 340,123.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$790.28 B 293,221.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
HK$11.50 B 4,168.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$17.85 B 6,527.77%๐Ÿ‡บ๐Ÿ‡ธ USA